Non-sustained ventricular tachycardia is an abnormally fast heart rate that occurs in the lower chambers of the heart and lasts for less than 30 seconds. Tachycardia is a heart rate that is faster ...

The use of sacubitril/valsartan appears feasible and safe in recipients of left ventricular assist devices, reducing the need ...

In 2006, Steve Pitkin suffered a serious heart attack while hiking above Salt Lake City with his daughter. The main artery in Pitkin’s heart was completely blocked, leaving 70% of his left ventricle ...

President Donald Trump's latest Oval Office appearance has sparked even more bizarre health concerns. On Wednesday, a TikTok user pointed out that they could see an LVAD (Left Ventricular Assist ...

BOSTON, MA—It may be possible to use a direct oral anticoagulant (DOAC) in advanced heart failure (HF) patients recently implanted with a left ventricular assist device (LVAD), according to results ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Dhruva is an ...

Please provide your email address to receive an email when new articles are posted on . The FDA designated Abbott/Thoratec Corp’s recall of two LVADs as class I, the most serious type. Long-term use ...

People are convinced they know exactly which procedure Donald Trump was doing when he was presumed dead over the weekend Speculation about President Donald Trump’s health has been steadily increasing ...

Toby Wise, 45, went into heart failure in 2021, and was put on an LVAD to help his heart pump. His heart recovered and the device was decommissioned. Sara Diggins is a visual journalist at the Austin ...

An Abbott recall concerns more than 1,500 of the tablet apps used to communicate with and control its implanted long-term heart pumps, after reports that software issues could cause the pumps to stop ...

Ventricular assist devices are mechanical pumps that take over the function of the damaged ventricle in order to re-establish normal hemodynamics and end-organ blood flow. In addition, VADs unload the ...

PONTE VEDRA, Fla.--(BUSINESS WIRE)--Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a late-stage biopharmaceutical company focused on the development of specialized cardiovascular therapeutics, with the ...